A tumor growth rate/overall survival model for atezolizumab as an early predictor of OS in patients with first or second line metastatic urothelial carcinoma Meeting Abstract
| Authors: | Bruno, R.; Claret, L.; Wu, B.; Jin, J. Y.; Winter, H.; Cui, N.; Derleth, C. L.; Shen, X.; Girish, S.; Rosenberg, J. E.; Powles, T. |
| Abstract Title: | A tumor growth rate/overall survival model for atezolizumab as an early predictor of OS in patients with first or second line metastatic urothelial carcinoma |
| Meeting Title: | 2018 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2018 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-10 |
| Language: | English |
| ACCESSION: | WOS:000436177700060 |
| DOI: | 10.1200/JCO.2018.36.5_suppl.62 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 62 -- Source: Wos |
